Report Detail
Global Varicella Vaccine Market Insights, Forecast to 2025
- RnM3041136 |
- 28 February, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
As for the global varicella vaccine industry, the industry structure is relatively concentrated. The 72.50% of market share in production is grasped by the top 5 manufacturers. The top three manufacturers are Merck, GSK and Shanghai Institute, which are close to 52 percent totally. The United States giant Merck, which has 30.40% market share in 2015, is the leader in the varicella vaccine industry. The manufacturers following Merck are GSK and Shanghai Institute, which respectively has 10.04% and 11.60% market share globally. The Shanghai Institute is the leader of China varicella vaccine industry.
The downstream industries of varicella vaccine products are kids and adults. In the recent years, with the recovery of global economic, the development of emerging countries and the rising health concern, the consumption increase of varicella vaccine will be obvious. In the foreseeable future, the varicella vaccine products will show an optimistic upward trend.
The growth rate in developed regions such as US and Europe is not very fast because they have higher product coverage. And the number of neonatal in their countries is decreasing. So the investors should pay more attention on developing countries such as south Asia, Latin America and Middle-east.
The global Varicella Vaccine market is valued at 3050 million US$ in 2018 and will reach 5550 million US$ by the end of 2025, growing at a CAGR of 7.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Varicella Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Varicella Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Varicella Vaccine in these regions.
This research report categorizes the global Varicella Vaccine market by top players/brands, region, type and end user. This report also studies the global Varicella Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Market size by Product
Injection
Freeze-dried powder
Market size by End User
Kids Injection
Adults Injection
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Varicella Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Varicella Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Varicella Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Varicella Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Varicella Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Varicella Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Varicella Vaccine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Varicella Vaccine Market Size Growth Rate by Product
- 1.4.2 Injection
- 1.4.3 Freeze-dried powder
- 1.5 Market by End User
- 1.5.1 Global Varicella Vaccine Market Size Growth Rate by End User
- 1.5.2 Kids Injection
- 1.5.3 Adults Injection
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Varicella Vaccine Market Size
- 2.1.1 Global Varicella Vaccine Revenue 2014-2025
- 2.1.2 Global Varicella Vaccine Sales 2014-2025
- 2.2 Varicella Vaccine Growth Rate by Regions
- 2.2.1 Global Varicella Vaccine Sales by Regions
- 2.2.2 Global Varicella Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Varicella Vaccine Sales by Manufacturers
- 3.1.1 Varicella Vaccine Sales by Manufacturers
- 3.1.2 Varicella Vaccine Sales Market Share by Manufacturers
- 3.1.3 Global Varicella Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.2 Varicella Vaccine Revenue by Manufacturers
- 3.2.1 Varicella Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Varicella Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.3 Varicella Vaccine Price by Manufacturers
- 3.4 Varicella Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Varicella Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Varicella Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Varicella Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Varicella Vaccine Sales by Product
- 4.2 Global Varicella Vaccine Revenue by Product
- 4.3 Varicella Vaccine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Varicella Vaccine Breakdown Data by End User
6 North America
- 6.1 North America Varicella Vaccine by Countries
- 6.1.1 North America Varicella Vaccine Sales by Countries
- 6.1.2 North America Varicella Vaccine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Varicella Vaccine by Product
- 6.3 North America Varicella Vaccine by End User
7 Europe
- 7.1 Europe Varicella Vaccine by Countries
- 7.1.1 Europe Varicella Vaccine Sales by Countries
- 7.1.2 Europe Varicella Vaccine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Varicella Vaccine by Product
- 7.3 Europe Varicella Vaccine by End User
8 Asia Pacific
- 8.1 Asia Pacific Varicella Vaccine by Countries
- 8.1.1 Asia Pacific Varicella Vaccine Sales by Countries
- 8.1.2 Asia Pacific Varicella Vaccine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Varicella Vaccine by Product
- 8.3 Asia Pacific Varicella Vaccine by End User
9 Central & South America
- 9.1 Central & South America Varicella Vaccine by Countries
- 9.1.1 Central & South America Varicella Vaccine Sales by Countries
- 9.1.2 Central & South America Varicella Vaccine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Varicella Vaccine by Product
- 9.3 Central & South America Varicella Vaccine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Varicella Vaccine by Countries
- 10.1.1 Middle East and Africa Varicella Vaccine Sales by Countries
- 10.1.2 Middle East and Africa Varicella Vaccine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Varicella Vaccine by Product
- 10.3 Middle East and Africa Varicella Vaccine by End User
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Merck Varicella Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Merck Varicella Vaccine Products Offered
- 11.1.5 Merck Recent Development
- 11.2 GSK
- 11.2.1 GSK Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GSK Varicella Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GSK Varicella Vaccine Products Offered
- 11.2.5 GSK Recent Development
- 11.3 Shanghai Institute
- 11.3.1 Shanghai Institute Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Shanghai Institute Varicella Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Shanghai Institute Varicella Vaccine Products Offered
- 11.3.5 Shanghai Institute Recent Development
- 11.4 BCHT
- 11.4.1 BCHT Company Details
- 11.4.2 Company Business Overview
- 11.4.3 BCHT Varicella Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 BCHT Varicella Vaccine Products Offered
- 11.4.5 BCHT Recent Development
- 11.5 Changsheng
- 11.5.1 Changsheng Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Changsheng Varicella Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Changsheng Varicella Vaccine Products Offered
- 11.5.5 Changsheng Recent Development
- 11.6 Keygen
- 11.6.1 Keygen Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Keygen Varicella Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Keygen Varicella Vaccine Products Offered
- 11.6.5 Keygen Recent Development
- 11.7 Green Cross
- 11.7.1 Green Cross Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Green Cross Varicella Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Green Cross Varicella Vaccine Products Offered
- 11.7.5 Green Cross Recent Development
- 11.8 Biken
- 11.8.1 Biken Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Biken Varicella Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Biken Varicella Vaccine Products Offered
- 11.8.5 Biken Recent Development
12 Future Forecast
- 12.1 Varicella Vaccine Market Forecast by Regions
- 12.1.1 Global Varicella Vaccine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Varicella Vaccine Revenue Forecast by Regions 2019-2025
- 12.2 Varicella Vaccine Market Forecast by Product
- 12.2.1 Global Varicella Vaccine Sales Forecast by Product 2019-2025
- 12.2.2 Global Varicella Vaccine Revenue Forecast by Product 2019-2025
- 12.3 Varicella Vaccine Market Forecast by End User
- 12.4 North America Varicella Vaccine Forecast
- 12.5 Europe Varicella Vaccine Forecast
- 12.6 Asia Pacific Varicella Vaccine Forecast
- 12.7 Central & South America Varicella Vaccine Forecast
- 12.8 Middle East and Africa Varicella Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Varicella Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Varicella Vaccine . Industry analysis & Market Report on Varicella Vaccine is a syndicated market report, published as Global Varicella Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Varicella Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
